ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹97 Cr | ₹106 Cr | ₹78 Cr | ₹60 Cr | ₹68 Cr |
What is the latest Total Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹97 Cr |
Mar2024 | ₹106 Cr |
Mar2023 | ₹78 Cr |
Mar2022 | ₹60 Cr |
Mar2021 | ₹68 Cr |
How is Total Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹97 Cr | -9.03 | |
Mar2024 | ₹106 Cr | 37.12 | |
Mar2023 | ₹78 Cr | 28.37 | |
Mar2022 | ₹60 Cr | -10.56 | |
Mar2021 | ₹68 Cr | - |
Compare Total Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,651.9 Cr | -2.2% | 0.5% | -13.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | -2.2% |
0.5% |
-13.4% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses